MediGene AG: Cancer-Fighting Virus Shows Promise In Early Clinical Trial
10-Jul-2007 -
A virus that has been specifically designed by scientists to be safe
to normal tissue but deadly to cancer is showing early promise in a
preliminary study, researchers said at the ESMO Conference
Lugano (ECLU), Switzerland.
The virus, called NV1020, is a type of herpes simplex virus modified
so ...
chemotherapy
clinical trials
colorectal cancer
+7